🇺🇸 FDA

Intelligence · Clinical Pipeline

Phase I Pipeline Programs

First-in-human and early clinical safety studies in Phase I.

Programs
4,713

Quick answer

NovaPharmaNews tracks 4,713 phase i pharmaceutical pipeline programs from ClinicalTrials.gov. First-in-human and early clinical safety studies in Phase I.

Top sponsors

Page 77 of 99

  1. SPR206

    Spero Therapeutics

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  2. SPR206

    CNS Pharmaceuticals

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  3. SPR720

    Spero Therapeutics

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  4. SPR720

    Spero Therapeutics

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  5. SPR720 for SAD

    Spero Therapeutics

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  6. SPR741

    Spero Therapeutics

    Healthy Volunteers

    phase 1 small molecule completed

    2 trials

  7. SPR994

    Spero Therapeutics

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  8. SPY001-001

    Spyre Therapeutics

    Healthy

    phase 1 small molecule completed

    1 trial

  9. SPY002-072

    Spyre Therapeutics

    Healthy

    phase 1 small molecule active

    1 trial

  10. SPY002-091

    Spyre Therapeutics

    Healthy

    phase 1 small molecule active

    1 trial

  11. SPY003-207

    Spyre Therapeutics

    Healthy

    phase 1 small molecule active

    1 trial

  12. SRF617

    Coherus Oncology

    Advanced Solid Tumor

    phase 1 small molecule completed

    1 trial

  13. SRP-1005

    Sarepta Therapeutics

    Huntington's Disease

    phase 1 small molecule active

    1 trial

  14. SRP-6004

    Sarepta Therapeutics

    Limb Girdle Muscular Dystrophy

    phase 1 gene therapy terminated

    1 trial

  15. SRP-9004

    Sarepta Therapeutics

    Limb Girdle Muscular Dystrophy

    phase 1 small molecule terminated

    1 trial

  16. SSGJ-612

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Advanced Malignant Tumors

    phase 1 small molecule active

    1 trial

  17. SSGJ-613

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Systemic Juvenile Idiopathic Arthritis

    phase 1 small molecule active

    1 trial

  18. SSGJ-613

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Arthritis, Gouty

    phase 1 small molecule active

    1 trial

  19. SSGJ-705

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Receptor, ErbB-2

    phase 1 small molecule active

    1 trial

  20. SSGJ-706

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Advanced Solid Tumors Patients

    phase 1 small molecule active

    1 trial

  21. SSGJ-709

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Advanced Malignant Tumors

    phase 1 small molecule active

    1 trial

  22. SSP-002358

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

  23. SSP-004184

    Takeda

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  24. SSP-004184

    Takeda

    Impaired Renal Function

    phase 1 small molecule completed

    1 trial

  25. SSP-004184AQ

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

  26. SSP-004184SS

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

  27. SSS11

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Gout

    phase 1 mab active

    1 trial

  28. SSS17

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Healthy Subjects (HS)

    phase 1 small molecule completed

    1 trial

  29. SSS17

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Anemia in Chronic Kidney Diseases

    phase 1 small molecule active

    2 trials

  30. SSS39

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Safety and Tolerability in Healthy Volunteers

    phase 1 small molecule active

    1 trial

  31. SSS55

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Safety Issues

    phase 1 small molecule active

    1 trial

  32. SSS59

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Malignant Tumors

    phase 1 small molecule active

    1 trial

  33. SSS67 Injection

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Healthy

    phase 1 small molecule active

    1 trial

  34. ST-2427

    BRIGHT MINDS BIOSCIENCES INC.

    Acute, Post-operative Pain

    phase 1 small molecule terminated

    1 trial

  35. ST1968

    BRIGHT MINDS BIOSCIENCES INC.

    Solid Tumors

    phase 1 small molecule completed

    1 trial

  36. STK-002

    Stoke Therapeutics

    Autosomal Dominant Optic Atrophy

    phase 1 small molecule active

    1 trial

  37. STP7 (mavoglurant)

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Use Disorder

    phase 1 small molecule completed

    1 trial

  38. STP705

    BRIGHT MINDS BIOSCIENCES INC.

    Hepatocellular Carcinoma

    phase 1 small molecule completed

    1 trial

  39. STRATIFY; Near-infrared fluorescence molecular imaging of adalimumab-800CW to elucidate the drug distribution throughout inflamed tissue in inflammatory bowel disease and rheumatoid arthritis

    Disc Medicine

    Crohn's disease, Spondyloarthritis, Rheumatoid arthritis, Ulcerative colitis

    phase 1 other active

    1 trial

  40. STRO-001

    SUTRO BIOPHARMA, INC.

    B-cell Lymphoma

    phase 1 small molecule completed

    1 trial

  41. STRO-002

    SUTRO BIOPHARMA, INC.

    Ovarian Cancer

    phase 1 small molecule completed

    2 trials

  42. STRO-004

    SUTRO BIOPHARMA, INC.

    Head and Neck Squamous Cell Carcinoma HNSCC

    phase 1 small molecule active

    1 trial

  43. SUZ

    Vertex Pharmaceuticals (Australia) Pty.

    Pain

    phase 1 small molecule completed

    1 trial

  44. SXC-2023

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Use Disorder

    phase 1 small molecule completed

    1 trial

  45. SYHA1813 oral solution (2.0g:25mg)

    Shanghai University of Traditional Chinese Medicine

    Healthy Participants

    phase 1 small molecule completed

    1 trial

  46. SYN115

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence

    phase 1 small molecule completed

    1 trial

  47. SYR-472

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

  48. SYS6055

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Relapsed/Refractory B-Cell Malignancies

    phase 1 small molecule active

    1 trial

Frequently asked questions

How many Phase I pipeline programs are in the directory?

4,713 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.